SCHEMBL4459279

SCHEMBL4459279

O=C(C(=NO)c1ccnc(Br)c1)c1ccc(F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
LTA4H P09960 1/20 0.39
KDM1A O60341 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
KMT2A Q03164 2/20 0.36
PTPN1 P18031 1/20 0.33
KDM5A P29375 1/20 0.33
KDM2B Q8NHM5 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
KDM5B Q9UGL1 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
RAB9A P51151 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
POLB P06746 1/20 0.32
NPC1 O15118 1/20 0.32
HTT P42858 1/20 0.32
HTR1F P30939 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4459277 1.00 CES2 (0.42) CES2CES1LTA4HKDM1AHDAC1
SCHEMBL828659 0.85 CES2 (0.44) CES2CES1LTA4HKMT2AKDM5A
SCHEMBL828398 0.85 CES2 (0.44) CES2CES1LTA4HKMT2AKDM5A
SCHEMBL830162 0.85 CES2 (0.44) CES2CES1LTA4HKMT2AKDM5A
SCHEMBL9953768 0.85 CES1 (0.55) CES2CES1LTA4HKDM1AHDAC1
SCHEMBL4466668 0.83 CES2 (0.42) CES2CES1LTA4HKMT2AKDM5A
SCHEMBL4466672 0.83 CES2 (0.42) CES2CES1LTA4HKMT2AKDM5A
SCHEMBL3615752 0.80 BRAF (0.44) CES2CES1KMT2AKDM5AKDM4C
SCHEMBL3615754 0.80 BRAF (0.44) CES2CES1KMT2AKDM5AKDM4C
SCHEMBL2847108 0.79 LTA4H (0.41) CES2CES1LTA4HKMT2AKDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582660-B2 2-thio-substituted imidazole derivatives and their use in pharmaceutics C-A-I-R BIOSCIENCES GMBH (DE) 2009-09-01 US disclosed
US-20060235054-A1 2-Thio-substituted imidazole derivatives and their use in pharmaceutics MERCKLE-GMBH (DE) 2006-10-19 US disclosed
EP-1539741-A1 2-THIO-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE IN PHARMACEUTICS MERCKLE GMBH (DE) 2005-06-15 EP disclosed
WO-2004018458-A1 2-THIO-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE IN PHARMACEUTICS MERCKLE-GMBH (DE) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235054-A1 2-Thio-substituted imidazole derivatives and their use in pharmaceutics IL2, TPMT, IFNG CES2 1940/4885CES1 964/4885LTA4H 703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.